Ftse Mib
33.220,31
-0,29%
DAX
18.067,91
-0,31%
S&P 500
5.487,03
0,25%
NASDAQ
17.862,23
0,03%
Bitcoin
65.184,25
0,33%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ INVO BioScience Inc (INVO) INVO BioScience Inc (INVO) Notizie

INVO BioScience Inc

INVO
0,94
-0,13 (-12,15%)
19 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/5/202422:39EDGAR2Form S-3 - Registration statement under Securities Act of..
15/5/202422:51EDGAR2Form 8-K - Current report
15/5/202422:15GLOBEINVO Reports Record First Quarter 2024 Financial Results
06/5/202423:30EDGAR2Form 8-K - Current report
17/4/202416:25APSMicro Cap Massively Bid Up Before Opening Bell
16/4/202422:59GLOBEINVO Reports Fourth Quarter and Full Year 2023 Financial..
06/2/202416:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202415:01EDGAR2Form 8-K - Current report
23/1/202414:00GLOBENAYA Biosciences To Acquire Clinical Stage Gene Therapy..
17/1/202414:00GLOBEINVO Bioscience Files S-4 Registration and Preliminary Joint..
16/1/202423:29EDGAR2Form S-4 - Registration of securities, business combinations
10/1/202422:46EDGAR2Form 8-K/A - Current report: [Amend]
10/1/202422:05EDGAR2Form 8-K - Current report
03/1/202423:29EDGAR2Form 8-K - Current report
28/12/202323:04EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
28/12/202323:02EDGAR2Form 8-K - Current report
13/12/202323:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
13/12/202322:53EDGAR2Form 8-K - Current report
11/12/202314:00PRNUSNAYA Biosciences Announces Publication of New Data for its..
28/11/202323:18EDGAR2Form 8-K - Current report
28/11/202315:00PRNUSINVO Bioscience Regains Compliance with Nasdaq Minimum..
24/11/202319:08EDGAR2Form DEF 14A - Other definitive proxy statements
20/11/202322:59EDGAR2Form 8-K - Current report
13/11/202322:10EDGAR2Form 8-K - Current report
13/11/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:01PRNUSINVO Reports Record Third Quarter 2023 Financial Results
13/11/202315:23EDGAR2Form SC TO-C - Written communication relating to an issuer..
13/11/202315:21EDGAR2Form 8-K - Current report
13/11/202315:12EDGAR2Form PRE 14A - Other preliminary proxy statements
10/11/202315:00PRNUSNAYA Biosciences and INVO Bioscience Announce Appointment of..
09/11/202322:40PRNUSINVO Bioscience Announces Commencement of Waiver..
27/10/202315:00PRNUSFree Registration Is Now Open For Tribe Public's CEO and Q&A..
26/10/202322:56EDGAR2Form 8-K - Current report
24/10/202323:10EDGAR2Form 8-K - Current report
23/10/202313:30PRNUSINVO Bioscience and NAYA Biosciences Announce Definitive..
16/10/202312:15EDGAR2Form 8-K - Current report
11/10/202315:00PRNUSINVO to Participate in the Lytham Partners Fall 2023..
05/10/202322:28EDGAR2Form 8-K - Current report
03/10/202323:24EDGAR2Form 8-K - Current report
02/10/202323:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/9/202323:26EDGAR2Form 8-K - Current report
29/9/202322:05PRNUSINVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF..
28/9/202318:45EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28/9/202318:30PRNUSINVO Reminds Shareholders to Cast Their Vote for Upcoming..
08/9/202322:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/9/202323:17EDGAR2Form 8-K - Current report
01/9/202315:55EDGAR2Form DEF 14A - Other definitive proxy statements
21/8/202322:33EDGAR2Form PRE 14A - Other preliminary proxy statements
14/8/202322:10EDGAR2Form 8-K - Current report
14/8/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 1,05 Min: 0,925 Max: 1,0653
Chiusura: 1,07

La tua Cronologia

NASDAQ
INVO
INVO BioScience
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network